Boston Trust Walden Corp Purchases 29,796 Shares of Procter & Gamble Company (The) $PG

Key Points

• Boston Trust Walden Corp increased its holdings in Procter & Gamble by 6.2%, acquiring an additional 29,796 shares, making their total ownership 512,119 shares valued at approximately $81.6 million.
• CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock, reflecting an 11.16% decrease in his ownership, valued at over $6.3 million.
• Procter & Gamble's quarterly earnings exceeded expectations with reported EPS of $1.48, prompting analysts to adjust their price targets, averaging around $172.21 with a consensus rating of "Moderate Buy."

Boston Trust Walden Corp boosted its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 6.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 512,119 shares of the company's stock after purchasing an additional 29,796 shares during the quarter. Boston Trust Walden Corp's holdings in Procter & Gamble were worth $81,591,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC lifted its position in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Northern Trust Corp lifted its position in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after acquiring an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD lifted its position in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after acquiring an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after buying an additional 1,018,865 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Insider Activity at Procter & Gamble

In other news, CEO Jon R. Moeller sold 40,119 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. This trade represents a 11.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the transaction, the insider owned 182,422 shares of the company's stock, valued at $28,689,507.94. This trade represents a 5.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 over the last ninety days. Insiders own 0.20% of the company's stock.

Procter & Gamble Trading Up 1.1%

Shares of NYSE PG opened at $149.18 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The firm has a 50 day moving average price of $155.15 and a two-hundred day moving average price of $159.20. The stock has a market cap of $349.15 billion, a P/E ratio of 22.92, a price-to-earnings-growth ratio of 3.91 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the company posted $1.40 EPS. The company's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble's dividend payout ratio (DPR) is 64.82%.

Analysts Set New Price Targets

Several brokerages recently weighed in on PG. UBS Group dropped their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research report on Wednesday, October 8th. Bank of America dropped their price objective on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research report on Wednesday, October 8th. JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research report on Friday, October 10th. Barclays dropped their price objective on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. Finally, BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research report on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $172.21.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.